SCHEMBL9841825

SCHEMBL9841825

CC1=CC(=O)C2=C(CCCC2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.40
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 3/20 0.39
MAPK1 P28482 3/20 0.39
BLM P54132 3/20 0.39
KMT2A Q03164 3/20 0.39
USP2 O75604 2/20 0.39
GAA P10253 2/20 0.39
TP53 P04637 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
HSPD1 P10809 2/20 0.39
HPGD P15428 2/20 0.39
CDC25A P30304 2/20 0.39
CDC25B P30305 2/20 0.39
HSPE1 P61604 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TST Q16762 2/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9817717 0.95 ALDH1A1 (0.39) CES1ALDH1A1MAPTMEN1MAPK1
SCHEMBL30596847 0.74 MEN1 (0.33) CES1ALDH1A1MAPTMEN1MAPK1
SCHEMBL8583617 0.73 XIAP (0.36) ALDH1A1MAPTMEN1MAPK1KMT2A
SCHEMBL8677812 0.73 ALDH1A1 (0.39) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL8758766 0.73 ALDH1A1 (0.39) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL9646046 0.72 MAPT (0.44) CES1ALDH1A1MAPTKMT2AHPGD
SCHEMBL8580595 0.72 HKDC1 (0.48) MAPTMEN1MAPK1KMT2AUSP2
SCHEMBL3270925 0.70 DNMT1 (0.44) ALDH1A1MAPTMEN1MAPK1BLM
SCHEMBL3624714 0.68 ALDH1A1 (0.50) CES1ALDH1A1MAPTMEN1MAPK1
SCHEMBL10638515 0.68 TRIM24 (0.47) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12576382-B2 Ceramic coating on metal parts to reduce deposit of metallic transition metals in hydrogenation reactions DSM IP ASSETS B.V. (NL) 2026-03-17 US disclosed
US-20230338915-A1 CERAMIC COATING ON METAL PARTS TO REDUCE DEPOSIT OF METALLIC TRANSITION METALS IN HYDROGENATION REACTIONS DSM IP ASSETS B.V. (NL) 2023-10-26 US disclosed
CN-116194204-A Ceramic coating for reducing deposition of metallic transition metals on metal parts in hydrogenation reactions 帝斯曼知识产权资产管理有限公司 2023-05-30 CN disclosed
WO-2022058576-A1 CERAMIC COATING ON METAL PARTS TO REDUCE DEPOSIT OF METALLIC TRANSITION METALS IN HYDROGENATION REACTIONS DSM IP ASSETS B.V. (NL) 2022-03-24 WO disclosed
US-5059598-A Antiinflammatory agents; lipoxygenase inhibitors; arthritis; asthma OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1991-10-22 US disclosed
US-4868183-A ANTIINFLAMMATORY, ENZYME INHIBITORS OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-09-19 US disclosed
EP-0254259-A2 p-Aminophenol derivatives OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1988-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576382-B2 Ceramic coating on metal parts to reduce deposit of metallic transition metals in hydrogenation reactions CAD, EZH2, ZW10 CES1 4324/4885ALDH1A1 3897/4885MAPT 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.